Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nurix Therapeutics

11.49
-0.1300-1.12%
Post-market: 11.490.00000.00%17:10 EDT
Volume:1.48M
Turnover:17.04M
Market Cap:875.95M
PE:-4.10
High:11.88
Open:11.73
Low:11.22
Close:11.62
Loading ...

Sanofi Exercises License Extension Option to Nurix’s Stat6 Program

THOMSON REUTERS
·
02 Jun

Barclays Reaffirms Their Buy Rating on Nurix Therapeutics (NRIX)

TIPRANKS
·
23 May

Nurix Therapeutics Holds 2025 Annual Stockholders Meeting

TIPRANKS
·
20 May

Nurix Therapeutics Inc. Conducted Its Annual Stockholders Meeting Virtually

Reuters
·
20 May

BRIEF-Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
17 May

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
17 May

Nurix Therapeutics Inc. CFO Hans van Houte Reports Disposal of Common Shares

Reuters
·
03 May

Innovative Capabilities and Promising Data Drive Buy Rating for Nurix Therapeutics

TIPRANKS
·
30 Apr

Nurix Says FDA Clears Oral IRAK4 Degrader Application for Inflammatory Diseases; Shares Up Pre-Bell

MT Newswires Live
·
17 Apr

BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479

Reuters
·
17 Apr

Nurix Therapeutics Inc - to Receive $5 Million Milestone Payment From Gilead

THOMSON REUTERS
·
17 Apr

Nurix Announces FDA Clearance of Ind Application for Gs-6791/Nx-0479 - a Novel Irak4 Degrader for Inflammatory Conditions

THOMSON REUTERS
·
17 Apr

Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions

GlobeNewswire
·
17 Apr

Stock Track | Nurix Therapeutics Plummets 7.50% as UBS Slashes Target Price

Stock Track
·
10 Apr

Stock Track | Nurix Therapeutics Plummets 7.50% as UBS Slashes Price Target

Stock Track
·
10 Apr

Nurix Therapeutics First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.
·
10 Apr

Stock Track | Nurix Therapeutics Soars 5.08% Despite Price Target Cuts as Analysts Maintain Buy Ratings

Stock Track
·
10 Apr

Stock Track | Nurix Therapeutics Plummets 5.13% as Multiple Analysts Cut Price Targets Ahead of Earnings

Stock Track
·
09 Apr

Stock Track | Nurix Therapeutics Plummets 5.13% as Analysts Cut Price Targets Ahead of Earnings

Stock Track
·
09 Apr

Nurix Therapeutics price target lowered to $32 from $35 at Oppenheimer

TIPRANKS
·
09 Apr